Anticuerpo bloqueador (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anticuerpo bloqueador" in Spanish language version.

refsWebsite

Global rank Spanish rank

4^th place

2^nd place

6^th place

5^th place

11^th place

79^th place

archive.org

«Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E». J. Virol. 82 (14): 6935-41. July 2008. PMC 2446985. PMID 18480440. doi:10.1128/JVI.02599-07.
Callahan, Margaret (26 de marzo de 2013). «At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy». Journal of Leukocyte Biology 94 (1): 41-53. PMC 4051187. PMID 23667165. doi:10.1189/jlb.1212631.
Kyi, Chrisann (23 de octubre de 2013). «Checkpoint blocking antibodies in cancer immunotherapy». Federation of European Biochemical Societies Letters 588 (2): 368-376. PMID 24161671. S2CID 3639538. doi:10.1016/j.febslet.2013.10.015.
Kyi, Chrisann; Postow, Michael (23 de octubre de 2013). «Checkpoint blocking antibodies in cancer immunotherapy». Federation of European Biochemical Societies Letters 588 (2): 368-376. PMID 24161671. doi:10.1016/j.febslet.2013.10.015.
Uthaipibull, Chairat (13 de abril de 2001). «Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum». Journal of Molecular Biology 307 (5): 1381-1394. PMID 11292349. doi:10.1006/jmbi.2001.4574.
Blackman, MJ (July 1996). «Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1.». Experimental Parasitology 83 (2): 229-39. PMID 8682191. doi:10.1006/expr.1996.0069.

«Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E». J. Virol. 82 (14): 6935-41. July 2008. PMC 2446985. PMID 18480440. doi:10.1128/JVI.02599-07.
Callahan, Margaret (26 de marzo de 2013). «At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy». Journal of Leukocyte Biology 94 (1): 41-53. PMC 4051187. PMID 23667165. doi:10.1189/jlb.1212631.
Kyi, Chrisann (23 de octubre de 2013). «Checkpoint blocking antibodies in cancer immunotherapy». Federation of European Biochemical Societies Letters 588 (2): 368-376. PMID 24161671. S2CID 3639538. doi:10.1016/j.febslet.2013.10.015.
Kyi, Chrisann; Postow, Michael (23 de octubre de 2013). «Checkpoint blocking antibodies in cancer immunotherapy». Federation of European Biochemical Societies Letters 588 (2): 368-376. PMID 24161671. doi:10.1016/j.febslet.2013.10.015.
Uthaipibull, Chairat (13 de abril de 2001). «Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum». Journal of Molecular Biology 307 (5): 1381-1394. PMID 11292349. doi:10.1006/jmbi.2001.4574.
Blackman, MJ (July 1996). «Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1.». Experimental Parasitology 83 (2): 229-39. PMID 8682191. doi:10.1006/expr.1996.0069.

Kyi, Chrisann (23 de octubre de 2013). «Checkpoint blocking antibodies in cancer immunotherapy». Federation of European Biochemical Societies Letters 588 (2): 368-376. PMID 24161671. S2CID 3639538. doi:10.1016/j.febslet.2013.10.015.